Skip to product information
1 of 9

Ovarian Cancer Socks - Boxed Set - PRE ORDER

Ovarian Cancer Socks - Boxed Set - PRE ORDER

Regular price $29.50 AUD
Regular price Sale price $29.50 AUD
Sale Sold out
Shipping calculated at checkout.

PRE ORDERS OPEN - Orders expected to ship early December. 

Limited edition boxed sock set featuring three pairs of luxuriously soft bamboo cotton socks with 100% of net proceeds going directly to the Ovarian Cancer Research Foundation, Australia's leading independent body dedicated to ovarian cancer research. The boxed set features unique designs crafted by 2024 Guest Desinger, Professor Carlos Salomon Gallo, a prominent leader in ovarian cancer research. Ovarian Cancer Socks are a great gift idea with optional ribbon and greeting card options available. If you added a card, type your custom message at checkout.

 Bamboo Cotton
 Reinforced heel & toe
 Help fund critical cancer research
 Great gift idea for a good cause

View full details

About Ovarian Cancer

Ovarian cancer is the most lethal reproductive cancer in Australia. Of the 1,815 Australian women diagnosed with ovarian cancer last year, only 889 of them (49%) will be alive five years from now. That's why we're partnering with the Ovarian Cancer Research Foundation because their core focus is on the development and implementation of a reliable early detection program as well as improved treatments for women.

2023 Guest Designer

We warmly welcome Zoe Conde, Digga Australia CEO and daughter of former Digga Australia CEO and Managing Director, the late Suzie Wright, as the 2023 inaugural Ovarian Cancer Socks Guest Designer as she seeks to commemorate the life of her incredible mother as well as advocate for a cause close to her heart. This is her story.

Our Story

Created and launched by the team at Digga Australia — a leading Australian manufacturer of earthmoving equipment — Ovarian Cancer Socks is an annual fundraiser donating 100% of all sales to much needed ovarian cancer research. Sadly, Digga Australia lost its CEO and Managing Director in 2018 after a short battle with ovarian cancer...

* Data taken from Cancer Australia